2 completed, 1 withdrawn. 3 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 2, Withdrawn 1 |
| Phase 2 | 1 | Completed 1 |
Follow tapinarof: new trials by email Literature Review of tapinarof trials Research Report on tapinarof
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study Comparing Tapinarof Cream 1% and Vtama® Cream 1% in the Treatment of Plaque Psoriasis. Tapinarof Cream, 1%, Vtama® (Tapinarof) Cream, 1%, Placebo Control - Plaque Psoriasis | Phase 1 | Completed | Sun Pharmaceutical Industries, Inc. | 575 | 2025-10-13 | 2026-04-22 |
| A Study to Evaluate Pharmacokinetic (PK), Safety and Tolerability of GSK2894512 in Healthy Adult Subjects GSK2894512 1% CREAM, GSK2894512 MATCHING VEHICLE CREAM - Psoriasis | Phase 1 | Withdrawn | GlaxoSmithKline | 2017-12-14 | 2017-11-29 | |
| Phase IIa Study of WBI-1001 Cream for Atopic Dermatitis WBI-1001 - Dermatitis, Atopic | Phase 1 / Phase 2 | Completed | Welichem Biotech Inc. | 36 | 2008-03-01 | 2009-02-05 |
Dermatitis, Atopic (1) · Psoriasis (1)
GlaxoSmithKline (1) · Sun Pharmaceutical Industries, Inc. (1) · Welichem Biotech Inc. (1)
Canada (1) · United States (1)
Natalie Yantovskiy (1) · Robert Bissonnette, MD (1)